|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| (Gain) loss on real estate ventures | |||||
| Distributions from real estate ventures | |||||
| Deferred income taxes | |||||
| Accrued interest income | |||||
| (Gain) loss on disposal of fixed assets | |||||
| Deferred compensation plan assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accrued personnel costs | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred compensation plan liabilities | |||||
| Other assets and liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Investments in real estate ventures | |||||
| Proceeds from sale of CES | |||||
| Distributions from real estate ventures | |||||
| Capitalized expenses for real estate ventures | |||||
| Purchase of deferred compensation plan securities | |||||
| Proceeds from sales of deferred compensation plan securities | |||||
| Purchase of fixed assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Redemption of Series C Preferred Stock | |||||
| Proceeds from issuance of common stock related to equity awards | |||||
| Payment of taxes related to the net share settlement of equity awards | |||||
| Net cash provided by (used in) financing activities | |||||
| Operating cash flows, net | |||||
| Investing cash flows, net | |||||
| Financing cash flows, net | |||||
| Net cash provided by (used in) discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental Cash Flow Information | |||||
| Interest | |||||
| Income taxes | |||||
| Issuance of Series A common stock to redeem Series C preferred stock | |||||
| Right of use assets and lease liabilities at commencement | |||||
Loading...
